Zimmer Biomet Holdings (ZBH) Financials & Stock Analysis

Zimmer Biomet Holdings

NYSE: ZBH · USD

Revenue

USD millions

$2,177M

Zimmer Biomet Holdings Revenue. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
Period	Revenue
FY 2009 Q2	$1,019.9M; Change unavailable vs FY 2009 Q1
FY 2009 Q3	$975.6M; −4.3% vs FY 2009 Q2
FY 2009 Q4	$1,107.3M; +13.5% vs FY 2009 Q3
FY 2010 Q1	$1,062.8M; −4.0% vs FY 2009 Q4
FY 2010 Q2	$1,057.7M; −0.5% vs FY 2010 Q1
FY 2010 Q3	$965M; −8.8% vs FY 2010 Q2
FY 2010 Q4	$1,134.7M; +17.6% vs FY 2010 Q3
FY 2011 Q1	$1,115.6M; −1.7% vs FY 2010 Q4
FY 2011 Q2	Unavailable; Change unavailable vs FY 2011 Q1
FY 2011 Q3	Unavailable; Change unavailable vs FY 2011 Q2
FY 2011 Q4	Unavailable; Change unavailable vs FY 2011 Q3
FY 2012 Q1	Unavailable; Change unavailable vs FY 2011 Q4
FY 2012 Q2	Unavailable; Change unavailable vs FY 2012 Q1
FY 2012 Q3	Unavailable; Change unavailable vs FY 2012 Q2
FY 2012 Q4	Unavailable; Change unavailable vs FY 2012 Q3
FY 2013 Q1	Unavailable; Change unavailable vs FY 2012 Q4
FY 2013 Q2	Unavailable; Change unavailable vs FY 2013 Q1
FY 2013 Q3	Unavailable; Change unavailable vs FY 2013 Q2
FY 2013 Q4	Unavailable; Change unavailable vs FY 2013 Q3
FY 2014 Q1	Unavailable; Change unavailable vs FY 2013 Q4
FY 2014 Q2	Unavailable; Change unavailable vs FY 2014 Q1
FY 2014 Q3	Unavailable; Change unavailable vs FY 2014 Q2
FY 2014 Q4	Unavailable; Change unavailable vs FY 2014 Q3
FY 2015 Q1	Unavailable; Change unavailable vs FY 2014 Q4
FY 2015 Q2	Unavailable; Change unavailable vs FY 2015 Q1
FY 2015 Q3	Unavailable; Change unavailable vs FY 2015 Q2
FY 2015 Q4	Unavailable; Change unavailable vs FY 2015 Q3
FY 2016 Q1	Unavailable; Change unavailable vs FY 2015 Q4
FY 2016 Q2	Unavailable; Change unavailable vs FY 2016 Q1
FY 2016 Q3	Unavailable; Change unavailable vs FY 2016 Q2
FY 2016 Q4	Unavailable; Change unavailable vs FY 2016 Q3
FY 2017 Q1	$1,972.4M; Change unavailable vs FY 2016 Q4
FY 2017 Q2	$1,949.5M; −1.2% vs FY 2017 Q1
FY 2017 Q3	$1,813.1M; −7.0% vs FY 2017 Q2
FY 2017 Q4	$2,068.3M; +14.1% vs FY 2017 Q3
FY 2018 Q1	$2,017.6M; −2.5% vs FY 2017 Q4
FY 2018 Q2	$2,007.6M; −0.5% vs FY 2018 Q1
FY 2018 Q3	$1,836.7M; −8.5% vs FY 2018 Q2
FY 2018 Q4	$2,071M; +12.8% vs FY 2018 Q3
FY 2019 Q1	$1,975.5M; −4.6% vs FY 2018 Q4
FY 2019 Q2	$1,988.6M; +0.7% vs FY 2019 Q1
FY 2019 Q3	$1,892.4M; −4.8% vs FY 2019 Q2
FY 2019 Q4	$2,125.7M; +12.3% vs FY 2019 Q3
FY 2020 Q1	$1,783.8M; −16.1% vs FY 2019 Q4
FY 2020 Q2	$1,226.1M; −31.3% vs FY 2020 Q1
FY 2020 Q3	$1,929.3M; +57.4% vs FY 2020 Q2
FY 2020 Q4	$2,085.3M; +8.1% vs FY 2020 Q3
FY 2021 Q1	$1,847.4M; −11.4% vs FY 2020 Q4
FY 2021 Q2	$2,026.9M; +9.7% vs FY 2021 Q1
FY 2021 Q3	$1,924M; −5.1% vs FY 2021 Q2
FY 2021 Q4	$2,037.9M; +5.9% vs FY 2021 Q3
FY 2022 Q1	$1,663.2M; −18.4% vs FY 2021 Q4
FY 2022 Q2	$1,781.8M; +7.1% vs FY 2022 Q1
FY 2022 Q3	$1,669.8M; −6.3% vs FY 2022 Q2
FY 2022 Q4	$1,825.1M; +9.3% vs FY 2022 Q3
FY 2023 Q1	$1,831M; +0.3% vs FY 2022 Q4
FY 2023 Q2	$1,869.6M; +2.1% vs FY 2023 Q1
FY 2023 Q3	$1,753.6M; −6.2% vs FY 2023 Q2
FY 2023 Q4	$1,940.1M; +10.6% vs FY 2023 Q3
FY 2024 Q1	$1,889.2M; −2.6% vs FY 2023 Q4
FY 2024 Q2	$1,942M; +2.8% vs FY 2024 Q1
FY 2024 Q3	$1,824.2M; −6.1% vs FY 2024 Q2
FY 2024 Q4	$2,023.2M; +10.9% vs FY 2024 Q3
FY 2025 Q1	$1,909.1M; −5.6% vs FY 2024 Q4
FY 2025 Q2	$2,077.3M; +8.8% vs FY 2025 Q1
FY 2025 Q3	$2,001.4M; −3.7% vs FY 2025 Q2
FY 2025 Q4	$2,243.8M; +12.1% vs FY 2025 Q3
FY 2026 Q1	$2,086.7M; −7.0% vs FY 2025 Q4
FY 2026 Q2	$2,177M; +4.3% vs FY 2026 Q1

Free cash flow

USD millions

$393.6M

Zimmer Biomet Holdings Free cash flow. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
Period	Free cash flow
FY 2009 Q2	$171.3M; Change unavailable vs FY 2009 Q1
FY 2009 Q3	$330.2M; +92.8% vs FY 2009 Q2
FY 2009 Q4	$357.2M; +8.2% vs FY 2009 Q3
FY 2010 Q1	$247.9M; −30.6% vs FY 2009 Q4
FY 2010 Q2	$257.6M; +3.9% vs FY 2010 Q1
FY 2010 Q3	$306.4M; +18.9% vs FY 2010 Q2
FY 2010 Q4	$302.4M; −1.3% vs FY 2010 Q3
FY 2011 Q1	$165.1M; −45.4% vs FY 2010 Q4
FY 2011 Q2	$234.1M; +41.8% vs FY 2011 Q1
FY 2011 Q3	$316.8M; +35.3% vs FY 2011 Q2
FY 2011 Q4	$347.1M; +9.6% vs FY 2011 Q3
FY 2012 Q1	$187.9M; −45.9% vs FY 2011 Q4
FY 2012 Q2	$206.7M; +10.0% vs FY 2012 Q1
FY 2012 Q3	$317.9M; +53.8% vs FY 2012 Q2
FY 2012 Q4	$324.7M; +2.1% vs FY 2012 Q3
FY 2013 Q1	$162.6M; −49.9% vs FY 2012 Q4
FY 2013 Q2	$167.3M; +2.9% vs FY 2013 Q1
FY 2013 Q3	$255.8M; +52.9% vs FY 2013 Q2
FY 2013 Q4	$277.4M; +8.4% vs FY 2013 Q3
FY 2014 Q1	$157.4M; −43.3% vs FY 2013 Q4
FY 2014 Q2	$222.1M; +41.1% vs FY 2014 Q1
FY 2014 Q3	$223.4M; +0.6% vs FY 2014 Q2
FY 2014 Q4	$305M; +36.5% vs FY 2014 Q3
FY 2015 Q1	$57.1M; −81.3% vs FY 2014 Q4
FY 2015 Q2	$156.4M; +173.9% vs FY 2015 Q1
FY 2015 Q3	$97.5M; −37.7% vs FY 2015 Q2
FY 2015 Q4	$338M; +246.7% vs FY 2015 Q3
FY 2016 Q1	$237.6M; −29.7% vs FY 2015 Q4
FY 2016 Q2	$341.1M; +43.6% vs FY 2016 Q1
FY 2016 Q3	$296.2M; −13.2% vs FY 2016 Q2
FY 2016 Q4	$572.6M; +93.3% vs FY 2016 Q3
FY 2017 Q1	$232.3M; −59.4% vs FY 2016 Q4
FY 2017 Q2	$409.8M; +76.4% vs FY 2017 Q1
FY 2017 Q3	$427.5M; +4.3% vs FY 2017 Q2
FY 2017 Q4	$356.7M; −16.6% vs FY 2017 Q3
FY 2018 Q1	$463.8M; +30.0% vs FY 2017 Q4
FY 2018 Q2	Unavailable; Change unavailable vs FY 2018 Q1
FY 2018 Q3	$422.6M; Change unavailable vs FY 2018 Q2
FY 2018 Q4	$332M; −21.4% vs FY 2018 Q3
FY 2019 Q1	$245.8M; −26.0% vs FY 2018 Q4
FY 2019 Q2	$242.1M; −1.5% vs FY 2019 Q1
FY 2019 Q3	$519.3M; +114.5% vs FY 2019 Q2
FY 2019 Q4	$371.5M; −28.5% vs FY 2019 Q3
FY 2020 Q1	$410.7M; +10.6% vs FY 2019 Q4
FY 2020 Q2	$-71.8M; −117.5% vs FY 2020 Q1
FY 2020 Q3	$350.7M; +588.4% vs FY 2020 Q2
FY 2020 Q4	$397.4M; +13.3% vs FY 2020 Q3
FY 2021 Q1	$219.1M; −44.9% vs FY 2020 Q4
FY 2021 Q2	$426.6M; +94.7% vs FY 2021 Q1
FY 2021 Q3	$378.9M; −11.2% vs FY 2021 Q2
FY 2021 Q4	$302.6M; −20.1% vs FY 2021 Q3
FY 2022 Q1	$279.3M; −7.7% vs FY 2021 Q4
FY 2022 Q2	$304.6M; +9.1% vs FY 2022 Q1
FY 2022 Q3	$403.6M; +32.5% vs FY 2022 Q2
FY 2022 Q4	$180.8M; −55.2% vs FY 2022 Q3
FY 2023 Q1	$261M; +44.4% vs FY 2022 Q4
FY 2023 Q2	$250.6M; −4.0% vs FY 2023 Q1
FY 2023 Q3	$253.3M; +1.1% vs FY 2023 Q2
FY 2023 Q4	$525.6M; +107.5% vs FY 2023 Q3
FY 2024 Q1	$172.9M; −67.1% vs FY 2023 Q4
FY 2024 Q2	$316.7M; +83.2% vs FY 2024 Q1
FY 2024 Q3	$351.2M; +10.9% vs FY 2024 Q2
FY 2024 Q4	$454.8M; +29.5% vs FY 2024 Q3
FY 2025 Q1	$338.2M; −25.6% vs FY 2024 Q4
FY 2025 Q2	$328.1M; −3.0% vs FY 2025 Q1
FY 2025 Q3	$363.7M; +10.9% vs FY 2025 Q2
FY 2025 Q4	$442.6M; +21.7% vs FY 2025 Q3
FY 2026 Q1	$323.1M; −27.0% vs FY 2025 Q4
FY 2026 Q2	$393.6M; +21.8% vs FY 2026 Q1

Net margin

9.11%

Zimmer Biomet Holdings Net margin. Reported fiscal history.
Fiscal period	%
FY 2009 Q2	20.6%
FY 2009 Q3	15.36%
FY 2009 Q4	14.02%
FY 2010 Q1	19.33%
FY 2010 Q2	15.65%
FY 2010 Q3	19.8%
FY 2010 Q4	3.08%
FY 2011 Q1	18.73%
FY 2011 Q2	—
FY 2011 Q3	—
FY 2011 Q4	—
FY 2012 Q1	—
FY 2012 Q2	—
FY 2012 Q3	—
FY 2012 Q4	—
FY 2013 Q1	—
FY 2013 Q2	—
FY 2013 Q3	—
FY 2013 Q4	—
FY 2014 Q1	—
FY 2014 Q2	—
FY 2014 Q3	—
FY 2014 Q4	—
FY 2015 Q1	—
FY 2015 Q2	—
FY 2015 Q3	—
FY 2015 Q4	—
FY 2016 Q1	—
FY 2016 Q2	—
FY 2016 Q3	—
FY 2016 Q4	—
FY 2017 Q1	15.18%
FY 2017 Q2	9.45%
FY 2017 Q3	5.45%
FY 2017 Q4	59.54%
FY 2018 Q1	8.66%
FY 2018 Q2	9.21%
FY 2018 Q3	8.83%
FY 2018 Q4	-43.51%
FY 2019 Q1	12.46%
FY 2019 Q2	6.72%
FY 2019 Q3	22.78%
FY 2019 Q4	15.09%
FY 2020 Q1	-28.51%
FY 2020 Q2	-16.85%
FY 2020 Q3	12.57%
FY 2020 Q4	16%
FY 2021 Q1	10.72%
FY 2021 Q2	7%
FY 2021 Q3	7.57%
FY 2021 Q4	-4.12%
FY 2022 Q1	0.85%
FY 2022 Q2	8.63%
FY 2022 Q3	11.62%
FY 2022 Q4	-7.15%
FY 2023 Q1	12.7%
FY 2023 Q2	11.21%
FY 2023 Q3	9.28%
FY 2023 Q4	21.61%
FY 2024 Q1	9.13%
FY 2024 Q2	12.5%
FY 2024 Q3	13.66%
FY 2024 Q4	11.84%
FY 2025 Q1	9.53%
FY 2025 Q2	7.36%
FY 2025 Q3	11.54%
FY 2025 Q4	6.21%
FY 2026 Q1	11.41%
FY 2026 Q2	9.11%

P/E

× · TTM · Daily

21.76×

Zimmer Biomet Holdings P/E. Monthly closing observations; inspect daily values with the chart arrow keys.
Close date	× · TTM · Daily	Financials through
2012-02-29	14.33×	2011-12-31
2012-03-30	15.17×	2011-12-31
2012-04-30	14.85×	2011-12-31
2012-05-31	14.22×	2012-03-31
2012-06-29	15.09×	2012-03-31
2012-07-31	13.81×	2012-03-31
2012-08-31	14.1×	2012-06-30
2012-09-28	15.43×	2012-06-30
2012-10-31	14.65×	2012-06-30
2012-11-30	15.24×	2012-09-30
2012-12-31	15.4×	2012-09-30
2013-01-31	17.23×	2012-09-30
2013-02-28	17.27×	2012-12-31
2013-03-28	17.33×	2012-12-31
2013-04-30	17.61×	2012-12-31
2013-05-31	17.54×	2013-03-31
2013-06-28	16.74×	2013-03-31
2013-07-31	18.65×	2013-03-31
2013-08-30	19.24×	2013-06-30
2013-09-30	19.98×	2013-06-30
2013-10-31	21.28×	2013-06-30
2013-11-29	23.22×	2013-09-30
2013-12-31	23.67×	2013-09-30
2014-01-31	23.87×	2013-09-30
2014-02-28	23.84×	2013-09-30
2014-03-31	21.57×	2013-12-31
2014-04-30	22.08×	2013-12-31
2014-05-30	23.8×	2013-12-31
2014-06-30	23.69×	2013-12-31
2014-07-31	22.83×	2013-12-31
2014-08-29	22.65×	2013-12-31
2014-09-30	22.93×	2013-12-31
2014-10-31	25.37×	2013-12-31
2014-11-28	25.61×	2013-12-31
2014-12-31	25.87×	2013-12-31
2015-01-30	25.57×	2013-12-31
2015-02-27	28.8×	2014-12-31
2015-03-31	28.12×	2014-12-31
2015-04-30	26.28×	2014-12-31
2015-05-29	27.3×	2014-12-31
2015-06-30	26.13×	2014-12-31
2015-07-31	24.9×	2014-12-31
2015-08-31	24.78×	2014-12-31
2015-09-30	22.47×	2014-12-31
2015-10-30	25.02×	2014-12-31
2015-11-30	104.99×	2015-09-30
2015-12-31	106.63×	2015-09-30
2016-01-29	103.17×	2015-09-30
2016-02-29	100.63×	2015-09-30
2016-03-31	148.65×	2015-12-31
2016-04-29	161.4×	2015-12-31
2016-05-31	254.03×	2016-03-31
2016-06-30	250.43×	2016-03-31
2016-07-29	272.81×	2016-03-31
2016-08-31	115.48×	2016-06-30
2016-09-30	115.84×	2016-06-30
2016-10-31	93.91×	2016-06-30
2016-11-30	57.35×	2016-09-30
2016-12-30	58.1×	2016-09-30
2017-01-31	66.62×	2016-09-30
2017-02-28	65.91×	2016-09-30
2017-03-31	68.75×	2016-09-30
2017-04-28	67.36×	2016-09-30
2017-05-31	67.11×	2016-09-30
2017-06-30	72.29×	2016-09-30
2017-07-31	68.3×	2016-09-30
2017-08-31	64.33×	2016-09-30
2017-09-29	65.92×	2016-09-30
2017-10-31	68.47×	2016-09-30
2017-11-30	65.93×	2016-09-30
2017-12-29	67.94×	2016-09-30
2018-01-31	71.57×	2016-09-30
2018-02-28	65.45×	2016-09-30
2018-03-29	61.39×	2016-09-30
2018-04-30	64.84×	2016-09-30
2018-05-31	62.78×	2016-09-30
2018-06-29	62.74×	2016-09-30
2018-07-31	70.67×	2016-09-30
2018-08-31	69.6×	2016-09-30
2018-09-28	74.02×	2016-09-30
2018-10-31	63.95×	2016-09-30
2018-11-30	65.88×	2016-09-30
2018-12-31	58.39×	2016-09-30
2019-01-31	61.68×	2016-09-30
2019-02-28	—	2018-12-31
2019-03-29	—	2018-12-31
2019-04-30	—	2018-12-31
2019-05-31	—	2018-12-31
2019-06-28	—	2018-12-31
2019-07-31	—	2018-12-31
2019-08-30	—	2019-06-30
2019-09-30	—	2019-06-30
2019-10-31	—	2019-06-30
2019-11-29	—	2019-09-30
2019-12-31	—	2019-09-30
2020-01-31	—	2019-09-30
2020-02-28	25.01×	2019-12-31
2020-03-31	18.57×	2019-12-31
2020-04-30	21.99×	2019-12-31
2020-05-29	69.2×	2020-03-31
2020-06-30	65.38×	2020-03-31
2020-07-31	73.87×	2020-03-31
2020-08-31	793.84×	2020-06-30
2020-09-30	767.13×	2020-06-30
2020-10-30	744.37×	2020-06-30
2020-11-30	—	2020-09-30
2020-12-31	—	2020-09-30
2021-01-29	—	2020-09-30
2021-02-26	—	2020-12-31
2021-03-31	—	2020-12-31
2021-04-30	—	2020-12-31
2021-05-28	62.33×	2021-03-31
2021-06-30	59.55×	2021-03-31
2021-07-30	60.51×	2021-03-31
2021-08-31	34.6×	2021-06-30
2021-09-30	33.66×	2021-06-30
2021-10-29	32.91×	2021-06-30
2021-11-30	30.74×	2021-09-30
2021-12-31	32.66×	2021-09-30
2022-01-31	31.62×	2021-09-30
2022-02-28	66.54×	2021-12-31
2022-03-31	68.92×	2021-12-31
2022-04-29	65.07×	2021-12-31
2022-05-31	116.01×	2022-03-31
2022-06-30	101.39×	2022-03-31
2022-07-29	106.54×	2022-03-31
2022-08-31	97.43×	2022-06-30
2022-09-30	95.8×	2022-06-30
2022-10-31	103.87×	2022-06-30
2022-11-30	90.89×	2022-09-30
2022-12-30	96.49×	2022-09-30
2023-01-31	96.36×	2022-09-30
2023-02-28	112.73×	2022-12-31
2023-03-31	117.58×	2022-12-31
2023-04-28	125.99×	2022-12-31
2023-05-31	59.58×	2023-03-31
2023-06-30	68.12×	2023-03-31
2023-07-31	64.64×	2023-03-31
2023-08-31	49.45×	2023-06-30
2023-09-29	46.59×	2023-06-30
2023-10-31	43.35×	2023-06-30
2023-11-30	51.5×	2023-09-30
2023-12-29	53.88×	2023-09-30
2024-01-31	55.61×	2023-09-30
2024-02-29	25.32×	2023-12-31
2024-03-28	26.87×	2023-12-31
2024-04-30	24.49×	2023-12-31
2024-05-31	24.63×	2024-03-31
2024-06-28	23.22×	2024-03-31
2024-07-31	23.82×	2024-03-31
2024-08-30	23.9×	2024-06-30
2024-09-30	22.35×	2024-06-30
2024-10-31	20.03×	2024-09-30
2024-11-29	21×	2024-09-30
2024-12-31	19.79×	2024-09-30
2025-01-31	20.51×	2024-09-30
2025-02-28	23.09×	2024-12-31
2025-03-31	25.05×	2024-12-31
2025-04-30	22.81×	2024-12-31
2025-05-30	20.4×	2024-12-31
2025-06-30	20.19×	2024-12-31
2025-07-31	20.28×	2024-12-31
2025-08-29	23.48×	2024-12-31
2025-09-30	21.8×	2024-12-31
2025-10-31	22.26×	2024-12-31
2025-11-28	21.58×	2024-12-31
2025-12-31	19.9×	2024-12-31
2026-01-30	19.27×	2024-12-31
2026-02-27	27.62×	2025-12-31
2026-03-31	25.37×	2025-12-31
2026-04-30	23.13×	2025-12-31
2026-05-29	21.18×	2026-03-31
2026-06-30	22.15×	2026-03-31
2026-07-31	24.16×	2026-03-31
2026-08-31	23.91×	2026-06-30
2026-09-25	21.76×	2026-06-30

ROIC

% · Annual / TTM

5.31%

Zimmer Biomet Holdings ROIC. Reported fiscal history.
Fiscal period	% · Annual / TTM
FY 2009 Q2	—
FY 2009 Q3	—
FY 2009 Q4	—
FY 2010 Q1	—
FY 2010 Q2	—
FY 2010 Q3	—
FY 2010 Q4	—
FY 2011 Q1	—
FY 2011 Q2	—
FY 2011 Q3	—
FY 2011 Q4	—
FY 2012 Q1	—
FY 2012 Q2	—
FY 2012 Q3	—
FY 2012 Q4	—
FY 2013 Q1	—
FY 2013 Q2	—
FY 2013 Q3	—
FY 2013 Q4	—
FY 2014 Q1	—
FY 2014 Q2	—
FY 2014 Q3	—
FY 2014 Q4	—
FY 2015 Q1	—
FY 2015 Q2	—
FY 2015 Q3	—
FY 2015 Q4	—
FY 2016 Q1	—
FY 2016 Q2	1.99%
FY 2016 Q3	2.96%
FY 2016 Q4	—
FY 2017 Q1	—
FY 2017 Q2	—
FY 2017 Q3	—
FY 2017 Q4	—
FY 2018 Q1	—
FY 2018 Q2	—
FY 2018 Q3	—
FY 2018 Q4	—
FY 2019 Q1	—
FY 2019 Q2	—
FY 2019 Q3	—
FY 2019 Q4	—
FY 2020 Q1	—
FY 2020 Q2	—
FY 2020 Q3	—
FY 2020 Q4	—
FY 2021 Q1	—
FY 2021 Q2	—
FY 2021 Q3	—
FY 2021 Q4	3.87%
FY 2022 Q1	3.53%
FY 2022 Q2	3.71%
FY 2022 Q3	4.35%
FY 2022 Q4	2.75%
FY 2023 Q1	3.56%
FY 2023 Q2	3.74%
FY 2023 Q3	3.42%
FY 2023 Q4	6.97%
FY 2024 Q1	6.62%
FY 2024 Q2	6.74%
FY 2024 Q3	—
FY 2024 Q4	6.24%
FY 2025 Q1	6.31%
FY 2025 Q2	5.67%
FY 2025 Q3	5.56%
FY 2025 Q4	4.93%
FY 2026 Q1	5.24%
FY 2026 Q2	5.31%

Capital allocation

% of tracked cash uses

$351.4M

Zimmer Biomet Holdings capital allocation. Quarterly values. Missing values are unavailable.
Period	Capex	Acquisitions	Buybacks	Dividends	Debt repayments	Tracked uses
FY 2009 Q2	39.53% · $23.8M	Unavailable	60.47% · $36.4M	Unavailable	Unavailable	100% · $60.2M
FY 2009 Q3	24.92% · $22.1M	Unavailable	75.08% · $66.6M	Unavailable	Unavailable	100% · $88.7M
FY 2009 Q4	5.17% · $28.3M	Unavailable	94.83% · $519.3M	Unavailable	Unavailable	100% · $547.6M
FY 2010 Q1	11.04% · $11.6M	Unavailable	88.96% · $93.5M	Unavailable	Unavailable	100% · $105.1M
FY 2010 Q2	15.02% · $15.1M	Unavailable	84.98% · $85.4M	Unavailable	Unavailable	100% · $100.5M
FY 2010 Q3	5.8% · $13.9M	Unavailable	94.2% · $225.7M	Unavailable	Unavailable	100% · $239.6M
FY 2010 Q4	27.65% · $38.6M	Unavailable	72.35% · $101M	Unavailable	Unavailable	100% · $139.6M
FY 2011 Q1	6.75% · $17.1M	Unavailable	93.25% · $236.1M	Unavailable	Unavailable	100% · $253.2M
FY 2011 Q2	12.25% · $16.9M	Unavailable	87.75% · $121.1M	Unavailable	Unavailable	100% · $138M
FY 2011 Q3	5.8% · $33.8M	Unavailable	94.2% · $549.3M	Unavailable	Unavailable	100% · $583.1M
FY 2011 Q4	24.27% · $46M	Unavailable	75.73% · $143.5M	Unavailable	Unavailable	100% · $189.5M
FY 2012 Q1	12.1% · $19.5M	Unavailable	87.9% · $141.6M	Unavailable	Unavailable	100% · $161.1M
FY 2012 Q2	18.89% · $24.8M	Unavailable	81.11% · $106.5M	Unavailable	Unavailable	100% · $131.3M
FY 2012 Q3	17.35% · $27.1M	Unavailable	62.48% · $97.6M	20.17% · $31.5M	Unavailable	100% · $156.2M
FY 2012 Q4	20.2% · $43.3M	Unavailable	65.25% · $139.9M	14.55% · $31.2M	Unavailable	100% · $214.4M
FY 2013 Q1	4.06% · $17.9M	Unavailable	88.93% · $392M	7.01% · $30.9M	Unavailable	100% · $440.8M
FY 2013 Q2	17.95% · $22.4M	Unavailable	55.13% · $68.8M	26.92% · $33.6M	Unavailable	100% · $124.8M
FY 2013 Q3	41.79% · $36.9M	Unavailable	19.82% · $17.5M	38.39% · $33.9M	Unavailable	100% · $88.3M
FY 2013 Q4	7.66% · $22.8M	Unavailable	80.91% · $240.7M	11.43% · $34M	Unavailable	100% · $297.5M
FY 2014 Q1	6.74% · $31.4M	Unavailable	85.96% · $400.5M	7.3% · $34M	Unavailable	100% · $465.9M
FY 2014 Q2	46.44% · $32M	Unavailable	0% · $0M	53.56% · $36.9M	Unavailable	100% · $68.9M
FY 2014 Q3	46.54% · $32.3M	Unavailable	0% · $0M	53.46% · $37.1M	Unavailable	100% · $69.4M
FY 2014 Q4	56.75% · $49.2M	Unavailable	0% · $0M	43.25% · $37.5M	Unavailable	100% · $86.7M
FY 2015 Q1	47.98% · $34.4M	Unavailable	Unavailable	52.02% · $37.3M	Unavailable	100% · $71.7M
FY 2015 Q2	44.84% · $30.4M	Unavailable	Unavailable	55.16% · $37.4M	Unavailable	100% · $67.8M
FY 2015 Q3	58.86% · $53.8M	0% · $0M	Unavailable	41.14% · $37.6M	Unavailable	100% · $91.4M
FY 2015 Q4	11.06% · $49.1M	Unavailable	Unavailable	10.09% · $44.8M	78.85% · $350M	100% · $443.9M
FY 2016 Q1	3.11% · $27.6M	Unavailable	46.81% · $415.5M	5.02% · $44.6M	45.06% · $400M	100% · $887.7M
FY 2016 Q2	23.78% · $46.1M	Unavailable	0% · $0M	24.65% · $47.8M	51.57% · $100M	100% · $193.9M
FY 2016 Q3	18.53% · $56.4M	Unavailable	0% · $0M	15.74% · $47.9M	65.72% · $200M	100% · $304.3M
FY 2016 Q4	26.94% · $54.6M	Unavailable	0% · $0M	23.73% · $48.1M	49.33% · $100M	100% · $202.7M
FY 2017 Q1	17.87% · $43.1M	Unavailable	Unavailable	19.94% · $48.1M	62.19% · $150M	100% · $241.2M
FY 2017 Q2	38.81% · $30.7M	Unavailable	Unavailable	61.19% · $48.4M	0% · $0M	100% · $79.1M
FY 2017 Q3	6.27% · $36M	Unavailable	Unavailable	8.44% · $48.5M	85.29% · $490M	100% · $574.5M
FY 2017 Q4	11.7% · $46.2M	Unavailable	Unavailable	12.31% · $48.6M	75.99% · $300M	100% · $394.8M
FY 2018 Q1	8.89% · $26.7M	Unavailable	Unavailable	16.18% · $48.6M	74.93% · $225M	100% · $300.3M
FY 2018 Q2	35.62% · $27M	Unavailable	Unavailable	64.38% · $48.8M	0% · $0M	100% · $75.8M
FY 2018 Q3	15.96% · $61.5M	Unavailable	Unavailable	12.67% · $48.8M	71.37% · $275M	100% · $385.3M
FY 2018 Q4	4.65% · $47.5M	Unavailable	Unavailable	4.8% · $49M	90.55% · $925M	100% · $1,021.5M
FY 2019 Q1	9.53% · $37.8M	Unavailable	Unavailable	12.35% · $49M	78.13% · $310M	100% · $396.8M
FY 2019 Q2	26.41% · $58.9M	Unavailable	Unavailable	22.02% · $49.1M	51.57% · $115M	100% · $223M
FY 2019 Q3	54.36% · $58.6M	Unavailable	Unavailable	45.64% · $49.2M	Unavailable	100% · $107.8M
FY 2019 Q4	51.19% · $51.8M	Unavailable	Unavailable	48.81% · $49.4M	Unavailable	100% · $101.2M
FY 2020 Q1	44.82% · $40.2M	Unavailable	Unavailable	55.18% · $49.5M	Unavailable	100% · $89.7M
FY 2020 Q2	27.7% · $19M	Unavailable	Unavailable	72.3% · $49.6M	Unavailable	100% · $68.6M
FY 2020 Q3	38.15% · $30.6M	Unavailable	Unavailable	61.85% · $49.6M	Unavailable	100% · $80.2M
FY 2020 Q4	35.74% · $27.7M	Unavailable	Unavailable	64.26% · $49.8M	Unavailable	100% · $77.5M
FY 2021 Q1	35.49% · $27.4M	Unavailable	Unavailable	64.51% · $49.8M	Unavailable	100% · $77.2M
FY 2021 Q2	35.32% · $27.3M	Unavailable	Unavailable	64.68% · $50M	Unavailable	100% · $77.3M
FY 2021 Q3	51.97% · $54.2M	Unavailable	Unavailable	48.03% · $50.1M	Unavailable	100% · $104.3M
FY 2021 Q4	55.69% · $63.1M	Unavailable	Unavailable	44.31% · $50.2M	Unavailable	100% · $113.3M
FY 2022 Q1	42.03% · $36.4M	Unavailable	Unavailable	57.97% · $50.2M	Unavailable	100% · $86.6M
FY 2022 Q2	44.85% · $40.9M	Unavailable	Unavailable	55.15% · $50.3M	Unavailable	100% · $91.2M
FY 2022 Q3	48.41% · $47.2M	Unavailable	Unavailable	51.59% · $50.3M	Unavailable	100% · $97.5M
FY 2022 Q4	55.71% · $63.4M	Unavailable	Unavailable	44.29% · $50.4M	0% · $0M	100% · $113.8M
FY 2023 Q1	11.72% · $46.7M	Unavailable	67.15% · $267.6M	12.62% · $50.3M	8.51% · $33.9M	100% · $398.5M
FY 2023 Q2	60.1% · $97.3M	Unavailable	8.83% · $14.3M	31.07% · $50.3M	0% · $0M	100% · $161.9M
FY 2023 Q3	62.72% · $84.3M	Unavailable	0% · $0M	37.28% · $50.1M	0% · $0M	100% · $134.4M
FY 2023 Q4	12% · $62.8M	Unavailable	78.41% · $410.3M	9.59% · $50.2M	0% · $0M	100% · $523.3M
FY 2024 Q1	25.26% · $55.1M	Unavailable	52.09% · $113.6M	22.65% · $49.4M	0% · $0M	100% · $218.1M
FY 2024 Q2	28.03% · $52.7M	Unavailable	45.69% · $85.9M	26.28% · $49.4M	0% · $0M	100% · $188M
FY 2024 Q3	6.45% · $44.5M	Unavailable	86.42% · $596.3M	7.13% · $49.2M	0% · $0M	100% · $690M
FY 2024 Q4	29.99% · $51.5M	Unavailable	42.05% · $72.2M	27.96% · $48M	0% · $0M	100% · $171.7M
FY 2025 Q1	13.84% · $44.6M	Unavailable	71.32% · $229.8M	14.84% · $47.8M	Unavailable	100% · $322.2M
FY 2025 Q2	47.81% · $50.1M	Unavailable	6.87% · $7.2M	45.32% · $47.5M	Unavailable	100% · $104.8M
FY 2025 Q3	53.66% · $55M	Unavailable	0% · $0M	46.34% · $47.5M	Unavailable	100% · $102.5M
FY 2025 Q4	20.09% · $74.8M	Unavailable	67.15% · $250M	12.76% · $47.5M	Unavailable	100% · $372.3M
FY 2026 Q1	10.89% · $36.3M	Unavailable	75.04% · $250.1M	14.07% · $46.9M	Unavailable	100% · $333.3M
FY 2026 Q2	15.42% · $54.2M	Unavailable	71.34% · $250.7M	13.23% · $46.5M	Unavailable	100% · $351.4M

Sources and calculations

Company filings · USD · Last checked 2026-10-18. Missing inputs remain unavailable. Your chart selection and layout are saved in this browser for Zimmer Biomet Holdings.

All charts share the selected dates. Quarterly/Yearly changes fiscal charts; valuation keeps completed daily closes on a published TTM basis. Later restatements can delay that basis. Historical mean, median and pricing labels use the selected range and do not estimate intrinsic fair value.

SBC deduction is an optional economic-cost scenario for FCF-based metrics. Missing SBC never becomes zero.

Revenue: Reported revenue from company filings.
Free cash flow: Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Net margin: Reported net income / revenue × 100.
P/E: Completed closing price × diluted shares / TTM earnings attributable to common shareholders.
ROIC: NOPAT / average invested capital × 100. NOPAT = operating income × (1 − effective tax rate). Invested capital = equity including noncontrolling interests + debt − cash and equivalents. Average uses period end and one year earlier.
Capital allocation: Reported cash uses as a percentage of tracked uses. Missing categories remain unavailable; SBC is noncash and excluded.

Reported revenue and sources

Zimmer Biomet Holdings financials